Kontafarma China Holdings Limited (HKG:1312)
0.0300
-0.0010 (-3.23%)
Apr 2, 2026, 3:59 PM HKT
Kontafarma China Holdings Revenue
In the year 2025, Kontafarma China Holdings had annual revenue of 914.71M HKD with 1.92% growth. Kontafarma China Holdings had revenue of 461.99M in the half year ending December 31, 2025, with 22.09% growth.
Revenue
914.71M
Revenue Growth
+1.92%
P/S Ratio
0.18
Revenue / Employee
1.40M
Employees
655
Market Cap
167.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 914.71M | 17.19M | 1.92% |
| Dec 31, 2024 | 897.52M | 88.41M | 10.93% |
| Dec 31, 2023 | 809.11M | -84.96M | -9.50% |
| Dec 31, 2022 | 894.06M | 90.80M | 11.30% |
| Dec 31, 2021 | 803.27M | -205.87M | -20.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 1.93B |
| Shenzhen Neptunus Interlong Bio-technique Company | 1.08B |
| Wai Yuen Tong Medicine Holdings | 721.27M |
| Qianhai Health Holdings | 677.12M |
| PuraPharm Corporation | 336.11M |
| Tianda Pharmaceuticals | 322.95M |
| Sanai Health Industry Group Company | 95.59M |
| Extrawell Pharmaceutical Holdings | 52.65M |